{
    "2020-05-26": [
        [
            {
                "time": "",
                "original_text": "中信建投医药|行业深度】血制品行业：供需格局改善，资源价值重塑",
                "features": {
                    "keywords": [
                        "血制品",
                        "供需格局",
                        "资源价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫情下的生物科技故事很燃：“新冠救星”还是“资本泡沫”",
                "features": {
                    "keywords": [
                        "疫情",
                        "生物科技",
                        "新冠",
                        "资本泡沫"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物新冠疫苗进入临床前动物试验，建设实验室和生产车间与研发疫苗同步",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "新冠疫苗",
                        "临床试验",
                        "实验室",
                        "生产车间"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华兰生物现7笔大宗交易 合计成交1.68亿元",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗新基建方向明确 机构称将拉动相关设备需求",
                "features": {
                    "keywords": [
                        "医疗新基建",
                        "设备需求"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基建"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华兰生物现7笔大宗交易 共成交16,761.43万元",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "56只送转股走出贴权走势",
                "features": {
                    "keywords": [
                        "送转股",
                        "贴权走势"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "股票市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "2020券商医药行业周观点（第17周）",
                "features": {
                    "keywords": [
                        "券商",
                        "医药行业",
                        "周观点"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药股持续走高，这10只被业内重点看好",
                "features": {
                    "keywords": [
                        "医药股",
                        "走高",
                        "业内看好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗新基建成两会热点 高瓴重点布局发挥市场化配置作用",
                "features": {
                    "keywords": [
                        "医疗新基建",
                        "两会热点",
                        "高瓴",
                        "市场化配置"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基建"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "全国人大代表安康建议：培育疾控人才 完善应急储备 扶助企业建立P3车间",
                "features": {
                    "keywords": [
                        "疾控人才",
                        "应急储备",
                        "P3车间"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "公共卫生"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "全国人大代表、华兰生物董事长安康：争分夺秒研发新冠疫苗 P3车间审批亟待提速",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "新冠疫苗",
                        "P3车间",
                        "审批提速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}